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Abstract
A number of studies have shown that both innate and adaptive immune defense mechanisms greatly influence the course
of human dengue virus (DENV) infections, but little is known about the innate immune response of the mosquito vector
Aedes aegypti to arbovirus infection. We present evidence here that a major component of the mosquito innate immune
response, RNA interference (RNAi), is an important modulator of mosquito infections. The RNAi response is triggered by
double-stranded RNA (dsRNA), which occurs in the cytoplasm as a result of positive-sense RNA virus infection, leading to
production of small interfering RNAs (siRNAs). These siRNAs are instrumental in degradation of viral mRNA with sequence
homology to the dsRNA trigger and thereby inhibition of virus replication. We show that although dengue virus type 2
(DENV2) infection of Ae. aegypti cultured cells and oral infection of adult mosquitoes generated dsRNA and production of
DENV2-specific siRNAs, virus replication and release of infectious virus persisted, suggesting viral circumvention of RNAi. We
also show that DENV2 does not completely evade RNAi, since impairing the pathway by silencing expression of dcr2, r2d2,
or ago2, genes encoding important sensor and effector proteins in the RNAi pathway, increased virus replication in the
vector and decreased the extrinsic incubation period required for virus transmission. Our findings indicate a major role for
RNAi as a determinant of DENV transmission by Ae. aegypti.
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Introduction
Dengue virus serotypes 1–4 (DENV1-4; Flavivirus; Flaviviridae)
are medically important, positive-sense RNA viruses transmitted
to humans by Aedes aegypti mosquitoes during epidemic outbreaks
[1,2]. DEN fever and DEN hemorrhagic fever are major public
health burdens in many parts of the world [3]; however, although
DENVs can cause severe disease in humans, mosquito infections
are non-pathogenic and persistent. We hypothesize that the
difference in infection outcomes results from host defense
(immune) responses. Ae. aegypti is an important vector because it
feeds almost exclusively on humans and is well adapted to life in
tropical urban environments [4]. We have only a rudimentary
understanding of DENV molecular interactions with Ae. aegypti
vectors, including the mosquito’s innate defense pathways against
arboviruses. DENVs infect the mosquito midgut following
ingestion of a viremic blood meal from an acutely infected
human, replicate, disseminate to the salivary glands where they are
further amplified, and emerge into saliva at the time of
transmission. Approximately 10 to 14 days are required for the
extrinsic incubation period (EIP), the time between initial infection
of the mosquito and transmission [5]. The recent release of the Ae.
aegypti genome sequence [6] provides an important tool to begin
understanding critical virus-vector interactions during the EIP.
Identification of mosquito genes that are orthologs of genes known
to be part of innate immune pathways in Drosophila [7,8] is an
important step in characterizing mosquito defense mechanisms
and makes it possible to manipulate putative antiviral pathways
during virus infection. Xi et al [8] have recently shown that the Ae.
aegypti Toll pathway, which is also implicated in Drosophila defense
against certain viruses, has a role in controlling DENV replication
after establishment of a persistent infection.
Recent studies with Drosophila clearly show that RNA interfer-
ence (RNAi) is a potent innate antiviral pathway that is
presumably triggered by dsRNA formed in virus-infected cells
and leads to degradation of the RNA virus genome. Several groups
have shown that RNAi can inhibit infection of Drosophila with
RNA viruses from the Dicistroviridae, Nodaviridae, and Togaviridae
families [9–11]. Mutant Drosophila lacking functional key RNAi
pathway genes such as dcr2 or ago2 are highly susceptible to some
RNA virus infections [9–11]. In Drosophila, dcr2 encodes the RNAi
sensor protein Dicer-2 (Dcr2) that recognizes and cleaves long
dsRNA, producing 21–25 bp short interfering RNAs (siRNAs)
[12,13]. siRNAs are duplexes with 39 overhangs of 2 nucleotides
and 59 phosphate and 39 hydroxyl ends [14]. With the assistance of
Dcr2 and the protein R2D2, one strand of siRNA is incorporated
into a nuclease complex called the RNA-induced silencing
complex (RISC), to start the effector phase of the pathway [15–
18]. The siRNA strand associated with RISC acts as a guide
sequence and anneals to target RNA having sequence comple-
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[17,19,20]. The Argonaute-2 (Ago2) protein in RISC has sequence
specific ‘‘slicer’’ activity and cleaves the target RNA, leading to its
degradation [21,22].
In silico searches using sequences of RNAi pathway genes from
Drosophila show a number of putative RNAi gene orthologs in
Anopheles gambiae and Ae. aegypti genome databases including dcr2,
r2d2 and ago2. We have carried out limited functional assays to
confirm the role of these genes in RNAi [23–27]. We have
demonstrated that Ago2 expression is essential in mosquitoes for
modulation of alphavirus (Togaviridae) infection of An. gambiae and
Ae. aegypti [25,27]. We also have demonstrated that RNAi that
inhibits the replication of DENV can be triggered in the midgut of
transgenic mosquitoes by expression of an inverted repeat RNA
(IR-RNA or dsRNA) derived from a portion of the DENV genome
prior to or at the same time as virus challenge in an infectious
blood-meal [23]. The Carb 77 transgenic line of mosquitoes
expressing DENV2-specific siRNAs generated from the trigger
sequence failed to accumulate viral genomic RNA, and poorly
disseminated and transmitted DENV2. Significantly, injection of
dsRNA derived from either Ae. aegypti ago2 or dcr2 sequences prior
to ingestion of an infectious blood-meal reversed the resistance
phenotype [23]; (Franz and Olson, unpublished data). These
studies demonstrated that the RNAi pathway is functional in the
mosquito midgut if artificially/exogenously triggered. However,
during natural, persistent infections of DENV2 competent
mosquitoes, viral RNA is readily detected in midguts from 2–
3 days post infection (dpi) to 14 days dpi [5,28], suggesting that
RNAi is not totally effective in preventing replication. An obvious
viral strategy to circumvent RNAi is to encode a suppressor of
RNAi and a number of examples of suppressors have been
described in plant and insect RNA viruses [29,30], although to
date no RNAi suppressors have been associated with arboviruses.
Alternatively, DENVs may simply evade RNAi by sequestering
their dsRNA replicative forms within virus-induced double
membrane structures associated with the endoplasmic reticulum,
preventing dsRNA recognition by an RNAi sensor [31,32]. A
focused study of DENV2 infection of competent Ae. aegypti should
reveal what role RNAi plays in this natural vector-virus
interaction. In this paper, we show that persistent DENV2
infections of Ae. aegypti cells and mosquitoes generate dsRNA
triggers and small DENV2-specific RNAs consistent in size and
sequence with siRNAs. Impairment of the RNAi pathway
increases the titer of infectious virus in the vector and shortens
the EIP, which could increase transmission efficiency.
Results
DENV2 growth in Ae. aegypti mosquito cells
We initially used cultured Ae. aegypti (Aag2) cells to examine RNAi
activity resulting from DENV infection. Triplicate flasks of confluent
Aag2 cells were infected at a multiplicity of infection (MOI) of 0.01
with DENV2 (Jamaica 1409, American-Asian genotype) and cell
culture medium was collected daily for titration of infectious virus.
Virustiterincreased dailyand peaked at7 dayspost infection(dpi) at
6.5610
562.3610
5 pfu/ml (Fig. 1A). DENV2 genomic RNA was
detected in cells infected at a MOI of 0.005 by northern blot analysis
at relatively high levels by 3 dpi and continuing to at least 7 dpi
(Fig. 1B). To determine if the infected cells contained dsRNA, the
RNAi trigger, we used the dsRNA-specific J2 antibody [33] in an
immunofluorescence assay (IFA) at 3 dpi. Cells that had been mock
infected displayed no fluorescence (Fig.1C.a), but strong signal was
detected in the cytoplasm of infected cells (Fig. 1C.b), presumably at
sites associated with viral replication. We looked for siRNA
production by northern blot analysis using total RNA isolated from
Aag2cells.SmallRNAsapproximately21 nt inlengthwere detected
withbothgenome-sense(Fig.1D.a)andantisense(Fig1D.b)DENV2
prM gene probes beginning at 3 dpi and continuing to 7 dpi. We
carried out limited cloning and sequencing of small RNA from Aag2
cells to verify the presence of DENV2 genome sequences and
detected a putative siRNA derived from the positive-sense strand of
the prM gene (nt 714–733; agtggcactcgttccacatg). Several groups of
overlapping 18–22 nt siRNAs appeared to be derived from genome
‘‘hot spots’’; for example, a total of 9 putative siRNAs were from the
nt 4659–5396 region ofthe NS3 gene,5 from the positive strand and
4 from the negative strand. Three of these formed an overlapping
cluster at nt 4962–4995 (J. Scott and J. Wilusz, unpublished results).
The most intense hybridization signal came from the negative sense
probe, suggesting that the majority of small RNAs were of the same
polarity as genomic RNA.
DENV2 growth in Ae. aegypti
Extensive spatial and temporal analyses were performed to
understand the DENV2 infection pattern in our model Higgs
white-eye (HWE) Rexville D strain of Ae. aegypti mosquitoes
following ingestion of an infectious artificial blood meal containing
approximately 10
7 pfu/ml of DENV2. Landmark events in the
infection pattern of Ae. aegypti HWE mosquitoes are summarized in
Figure 2. Infectious virus titers followed a similar pattern as
described previously using the same virus strain and various Ae.
aegypti strains [5,34] (Fig. 2A). Virus titers increased in the midgut
beginning at 3–5 dpi, peaked at 10 dpi (9610
363.6610
3 pfu/ml),
and began to decline by 12 dpi (7.4610
262.9610
2 pfu/ml). For
HWE mosquitoes, DENV2 envelope (E) antigen was readily
detected by IFA in the midgut at 7 and 14 dpi (Fig. 2B.a;
Fig. 2B.b), virus dissemination to fat body was detected at about
7 dpi (Fig. 2B.c), and antigen was found abundantly in salivary
glands at 14 dpi (Fig. 2B.d). Viral E antigen and virus titer
declined in the midgut by 14 dpi but increased in the salivary
glands from 14–21 dpi (9.4610
463.6610
4 pfu/ml virus titer in
carcass at 16 dpi). Viral RNA could be detected from 5 to 14 dpi
by northern blot analysis of total RNA from midguts (Figure 2C).
Author Summary
Dengue viruses, globally the most prevalent arboviruses,
are transmitted to humans by persistently infected Aedes
aegypti mosquitoes. Understanding the mechanisms mos-
quitoes use to modulate infections by these agents of
serious human diseases should give us critical insights into
virus–vector interactions leading to transmission. RNA
interference (RNAi) is an innate defense mechanism used
by invertebrates to inhibit RNA virus infections; however,
little is known about the antiviral role of RNAi in
mosquitoes. RNAi is triggered by double-stranded RNA,
leading to degradation of RNA with sequence homology
to the dsRNA trigger. We show that dengue virus type 2
(DENV2) infection of Ae. aegypti by the natural route
generates dsRNA and DENV2-specific small interfering
RNAs, hallmarks of the RNAi response; nevertheless,
persistent infection of mosquitoes occurs, suggesting that
DENV2 circumvents RNAi. We also show that DENV2
infection is modulated by RNAi, since impairment by
silencing expression of genes encoding important sensor
and effector proteins in the RNAi pathway increases virus
replication in the vector and decreases the incubation
period before virus transmission. Our findings indicate a
significant role for RNAi in determining the mosquito
vector’s potential for transmitting human diseases.
RNAi Modulates Dengue Infections
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could be detected outside the midgut from 9 to 14 dpi, when the
experiment was terminated. In previous studies we have shown
that by allowing infected mosquitoes to probe an artificial feeding
membrane, we can most consistently detect DENV2 in saliva of
HWE mosquitoes at 14 dpi [23].
Detection of dsRNA and siRNAs in mosquitoes following
DENV2 infection
The J2 antibody was used to detect dsRNA in midguts, the first
mosquito tissue infected after acquisition of a DENV2-containing
blood meal. Midguts from mosquitoes that received a blood meal
with no virus showed no fluorescent signal (Fig. 3A.a); however,
midguts from mosquitoes that had ingested the virus in a blood
meal 7 days earlier (Fig. 3A.b) produced a signal reminiscent of
DENV2 infection patterns seen by IFA for viral E antigen at the
same time point (Fig. 2B.a; [5]. This indicated that DENV2
infection of mosquito tissues also generates the RNAi trigger.
To detect virus-specific siRNAs in infected midguts, total RNA
was enriched for small RNAs as previously described [23]. An
antisense RNA oligonucleotide from the prM gene that had been
previously characterized by cloning and sequencing siRNA was
used as an RNase protection probe to detect DENV RNA-derived
siRNA in infected midguts [23]. We detected 22 nt RNA at 8 and
14 dpi (Figure 3B). To further verify the existence of siRNAs in
mosquitoes following infection, we performed northern blot
analysis on total mosquito RNA extracted 14 days after DENV2
infection using an antisense RNA prM probe and detected viral-
specific RNAs 22–24 nt in size (Fig. 3C). Thus, in both infected
mosquitoes (Fig. 2C and 3B and C) and cultured cells (Fig. 1B and
1D) we demonstrated that viral genomic RNA accumulated
concurrently with increasing levels of virus-specific small RNAs,
suggesting that the virus employs a mechanism to circumvent the
RNAi defense.
DENV2 growth in mosquitoes after impairment of the
RNAi pathway
We and other investigators have demonstrated that it is possible
to transiently silence (or impair) expression of key components of
the RNAi pathway by RNAi knock-down [23–25,29]. We found
Figure 1. DENV2 infection of Aag2 cells. (A) Growth curve of DENV2 in Aag2 cells. Virus titers in cell culture medium were determined by plaque
assay. (B) Detection of DENV2 genomic RNA in Aag2 cells by northern blot analysis (5 mg total RNA/lane). Stained ribosomal RNA is shown as loading
control. (C) Detection of dsRNA in mock infected (a) and DENV2 infected (b) Aag2 cells using the dsRNA-specific J2 antibody in an indirect
immunofluorescence assay (IFA). (D) Detection of DENV2 genome-derived small RNAs consistent in size with siRNAs on successive days after
infection. Small RNAs were detected using sense (a) and antisense (b) riboprobes from the prM gene of DENV2.
doi:10.1371/journal.ppat.1000299.g001
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Carb77 transgenic mosquitoes caused impairment of antiviral
RNAi, reversing the DENV2-resistant phenotype [23]. To
determine if modulation of the RNAi pathway in normal mosquito
vectors had an effect on virus replication we injected dsRNA to
knock-down expression of key pathway components Aa-dcr2, Aa-
r2d2, and Aa-ago2. Primers targeting specific regions of each
mRNA and used to generate dsRNAs are listed in Table 1. We
intrathoracically injected groups of 200 HWE mosquitoes with
500 ng of dsRNA derived from Aa-dcr2, Aa-r2d2, Aa-ago2, E. coli
bgal or with PBS. Five mosquitoes from each group were analyzed
by northern blot at 2 days after injection to demonstrate silencing
of Aa-ago2 mRNA with dsRNA.ago2 (Fig 4A.a), Aa-r2d2 mRNA
with dsRNA.r2d2, (Fig. 4A.b), and Aa-dcr2 mRNA with
dsRNA.dcr2 (Fig.4A.c) at the time of oral infection with DENV2,
which is most crucial in innate defense. Injection of dsRNA.bGAL
slightly enhanced, in the cases of Aa-r2d2 and Aa-dcr2, and slightly
reduced, in the case of Aa-ago2, but did not silence any of the
RNAi component mRNAs. Although normal levels of mRNA
were detectable in some mosquitoes after injection of
dsRNA.ago2, injection of dsRNA.dcr2 and dsRNA.r2d2 caused
almost complete silencing of cognate mRNA in all mosquitoes
tested. To assess the effect of silencing RNAi pathway genes on
DENV2 replication, dsRNA-injected mosquitoes were allowed to
recover for 2 days, then given an infectious blood meal.
Mosquitoes were assayed for infectious virus 7 days later (Fig 4B).
The titers in both groups of control mosquitoes, non-injected and
injected with dsRNA.bGAL (1.6610
367610
2 pfu/ml and
2.7610
366.5610
2 pfu/ml, respectively) were similar, as were
the percentages of mosquitoes infected [59% (30/51), and 52%
(36/71), respectively]. In mosquitoes injected with dsRNA.ago2
the titer (1.2610
466.5610
3 pfu/ml) and the number of mosqui-
toes infected (47%; 36/68) was similar to the non-injected group.
In contrast, in mosquitoes injected with dsRNA.r2d2 the infectious
virus titer was higher (7.0610
361.5610
3 pfu/ml; P,0.05) than in
the non-injected group; however, the percentage of mosquitoes
infected (55%; 44/80) was not different from the non-injected
group. The most profound effect on DENV2 infection was
observed in mosquitoes injected with dsRNA.dcr2 where both the
infectious titer (2.5610
461.0610
4 pfu/ml) and the proportion of
mosquitoes infected (75%; 63/84) were higher (P,0.05) than the
non-injected group.
Figure 2. DENV2 infection of Aedes aegypti HWE mosquitoes. (A) DENV2 titers in midguts (red symbols/line) and remaining tissues (carcass;
blue symbols/line) of individual mosquitoes at pre-determined days post-infection (dpi). (B) Detection of DENV2 E antigen by indirect IFA in midgut (a
and b) and salivary gland (c and d) tissue at 7 (a and c) and 14 (b and d) dpi. Insets in panels a and c show IFAs of midguts and salivary glands from
non-infected mosquitoes. (C) Northern blot hybridization to determine accumulation of DENV2 genomic RNA in midguts and carcasses from 5 to
14 days post-infection (5 mg total RNA/lane). Ethidium bromide-stained rRNA shown as loading controls. NBF=non-bloodfed (non-infected).
doi:10.1371/journal.ppat.1000299.g002
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northern blot analysis 16 days after injection with dsRNA and
14 days after virus challenge. In general, we observed a slight
increase in levels of viral RNA in mosquitoes injected with
dsRNA.ago2 and dsRNA.r2d2 as compared to control mosquitoes
(Fig. 4C). A greater than 4-fold increase in DENV2 genomic RNA
signal over controls was seen in mosquitoes injected with
dsRNA.dcr2, suggesting that impairment of RNAi early in
infection leads to more robust replication of viral RNA in the
mosquito.
Figure 3. Detection of dsRNA and DENV2-derived small RNAs in infected HWE mosquitoes. (A) Detection of dsRNA in midguts of mock
infected (a) and DENV2 infected (b) Ae. aegypti using the dsRNA-specific J2 antibody in indirect IFA. (B) Detection of small RNAs in total RNA from
DENV2 infected mosquito midguts at various time-points after infection by hybridization with a
32P-labeled 22 nt RNA probe complementary
(antisense) to the DENV2 prM gene in an RNase protection assay [23]. (C) Northern blot analysis of small RNAs in whole mosquitoes 14 days post
infection with DENV2 using a
32P-labeled antisense RNA probe from a 298 nt region of the DENV2 prM gene.
doi:10.1371/journal.ppat.1000299.g003
Table 1. Primers used for the generation of dsRNAs targeting RNAi pathway genes.
Gene GenBank* or Vectorbase ID no. Sequence, 59-39 Target nucleotides Region
Aa-dcr2 AY713296* Forward GCATTGACGACGAAATCATCGTCCGATG 3758–4250 RNA binding domain
Reverse ACCATGGCATCCGCCGGTGTCTTGTCC
Aa-r2d2 AAEL011753 Forward ATGGCCTCAAAGCCAGTCCTGAGCAC 76–575 RNA binding domain
Reverse TTGCAGCGTTCTTAATCATCTCGTTGCACG
Aa-ago2 Ae. aegypti Contig_5339 Forward ATGTAGACGCGTCCTCTGT 2380–2880 PIWI domain
Reverse ACAGTTCAAGCAGACGAACC
T7 promoter (not shown) was added to the 59 end of each primer for in vitro transcription of dsRNA.
doi:10.1371/journal.ppat.1000299.t001
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Ae. aegypti
To determine if transient impairment of RNAi pathway gene
expression affected the length of the extrinsic incubation period
(EIP) of DENV2 in Ae. aegypti HWE mosquitoes we injected
groups of 200 mosquitoes with dsRNA.ago2, dsRNA.r2d2,
dsRNA.dcr2, dsRNA.bGAL, or PBS and included one non-
injected group. Two days later all mosquito groups received an
infectious blood meal. Mosquitoes from each group that were
engorged with blood were placed into cartons (10 mosquitoes/
carton). At 7, 10, and 12 days after infection, mosquitoes in four
cartons from each group were allowed to probe an artificial
feeding solution for collection of saliva. The feeding solutions
were assayed for infectious virus and their mean titers are shown
in Figure 5A–C. Virus titers in individual mosquitoes were also
determined (data not shown) and indicated that all mosquitoes
were infected; therefore lack of virus titer in the feeding solutions
was not due to absence of infection.
Impairment of certain components of the RNAi pathway by
injection of dsRNA resulted in significant effects (P,0.05) on time
of appearance and titer of infectious virus in mosquito saliva. On
days 10 and 12 post infection (Fig 5B and 5C), the infectious virus
titers in feeding solutions from at least one of the mosquito groups
with impaired RNAi (dsRNA.dcr2-, dsRNA.ago2-, and
dsRNA.r2d2-injected) were higher (P,0.05) than in control
groups (dsRNA.bGAL-injected, PBS-injected, and non-injected).
At day 7, the titers in feeding solutions were not significantly
different (Fig. 5A). At day 10, feeding solutions collected from
dsRNA.dcr2-injected mosquitoes had significantly higher titers
(P,0.05) than control groups (dsRNA.bGAL-injected, PBS-
injected, and non-injected) (Fig. 5B). At day 12 the feeding
solution titers from dsRNA.dcr2- and dsRNA.ago2-injected
Figure 4. Effects of silencing expression of key RNAi genes prior to DENV2 infection. (A) Northern blot analysis showing RNA silencing of
RNAi component genes in individual mosquitoes (3 mg total RNA/lane). Blots were hybridized with antisense
32P-dCTP-labeled DNA probes amplified
from Aa-ago2 (a), Aa-r2d2 (b) and Aa-dcr2 (c) genes. Ribosomal RNAs are shown as loading controls. (B) Mean DENV2 titers 7 dpi in individual Ae.
aegypti with an impaired RNAi pathway. Mosquitoes were either non-injected or injected with 500 ng of dsRNA.bGAL, dsRNA.ago2, dsRNA.r2d2, or
dsRNA.dcr2 and allowed to recover for 2 days, then given a blood meal containing ,10
7 pfu/ml of DENV2. (Bars indicate mean values of titers 6SEM,
* indicate P,0.05). (C) Detection of DENV2 genomic RNA by northern blot analysis in whole Ae. aegypti at 14 days after virus challenge.
Approximately 5 mg of the total RNA extracted from 60 mosquitoes were loaded in each lane. Blots were hybridized with a
32P-labeled cDNA probe
derived from the prM sequence of DENV2 RNA. Ribosomal RNAs are shown as loading controls. Quantitation of RNA signal was performed using a
phosphorimager.
doi:10.1371/journal.ppat.1000299.g004
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control groups, and dsRNA.r2d2-injected mosquito saliva titer was
higher (P,0.05) than the non-injected group (Fig. 5C). Analysis by
Chi-square test revealed that dsRNA.dcr2-injected mosquitoes
had a significantly higher (P=0.053) number of infected feeding
solutions compared to the non-injected group at 7 dpi (Fig. 5A). At
10 dpi dsRNA.r2d2- and dsRNA.dcr2-injected groups had
increased proportions (P,0.05) of feeding solutions infected
compared to the non-injected group (Fig. 5B). At 12 dpi,
dsRNA.ago2-, dsRNA.r2d2- and dsRNA.dcr2-injected groups
had higher proportions (P,0.05) of feeding solutions infected
(Fig. 5C).
Discussion
We previously have identified a number of putative RNAi genes
in An. gambiae and Ae. aegypti genome databases, including dcr2, r2d2
and ago2, and by limited functional assays have confirmed the role
of dcr2 and ago2 in RNAi [23–27]; (Franz and Olson, unpublished
data). We also have demonstrated that the RNAi pathway in Ae.
aegypti inhibits the replication of alphaviruses and flaviviruses if first
triggered by introducing dsRNA derived from virus genome
sequences [23,26,27]. We show here that RNAi is implemented
naturally after acquisition of DENV2 by mosquitoes via the
normal, oral route of infection. DENV2 replication generated
virus-specific small RNAs, consistent in size with siRNAs, in
mosquito cell cultures as well as tissues of female mosquitoes.
However, despite the presence of siRNAs in their tissues, DENV2-
competent mosquitoes accumulated viral genome RNA and
infectious virus in midguts and other tissues and transmitted virus
in saliva. We found that RNAi-mediated knock-down of Aa-r2d2,
as well as Aa-ago2 and Aa-dcr2, resulted in increased virus
replication and shortened EIP in Ae. aegypti.
Cultured Ae. aegypti cells became persistently infected and
released increasing titers of infectious virus until at least 10 dpi.
DENV2-competent mosquitoes accumulated viral RNA and
infectious virus in the midgut up to 10 dpi. The decline in virus
titer and E antigen in the midgut after 10 dpi may have been a
result of clearance of virus by defense mechanisms mediated by
RNAi as well as the Toll pathway [8] or due to the nutritional
status of the mosquito, since these mosquitoes were not given
multiple blood meals; however, we found that the DENV2
infection persisted in tissues outside the midgut, including salivary
glands, to at least 21 dpi, which is consistent with previous findings
[5].
DENV2 infections generated substantial amounts of dsRNA in
infected Aag2 cells and midguts of Ae. aegypti mosquitoes. Others
have shown by IFA that dsRNA generated in DENV2-infected
mammalian cells co-localizes with non-structural viral proteins
known to be part of the replication complex within double-
membrane vesicles [35]. The fact that we detected siRNA-like
RNAs by northern blot hybridization using both sense and
antisense probes suggests that dsRNAs associated with DENV2
replication are vulnerable to cleavage by Dcr-2 protein. This was
particularly true in Aag2 cells, where we detected antisense
siRNAs that undoubtedly resulted from processing of dsRNA that
was a part of a replication intermediate. However, in contrast to
mosquito cells where RNAi is induced by expression of a dsRNA
transcript and siRNA polarity appears to be symmetrical [23,26],
in infected Aag2 cells we observed a preponderance of DENV2-
specific siRNAs arising from the genome strand, suggesting that
intramolecular secondary structure of viral genomic RNA may
account for much of the dsRNA cleaved by Dcr2 to produce
siRNAs. Others have shown similar asymmetry in siRNA polarity
and have hypothesized that secondary structure of genomic RNA
for some positive strand RNA viruses of plants and animals
contributes substantially to siRNA formation [36,37]. The
sequences of the DENV2-specific siRNAs will be analyzed to
accurately describe the population of 20–26 nt RNAs in DENV2
infected mosquito cells.
To show that the RNAi pathway affects virus replication in a
competent DENV2 vector, we transiently silenced key RNAi
pathway genes and examined resulting changes in virus titer.
Previously, we have shown that injection of dsRNA derived from
An. gambiae ago2 gene sequence transiently impaired the RNAi
pathway and significantly increased replication of O’nyong-nyong
virus (genus, Alphavirus; family Togaviridae) in the vector [25]. We
suggested that a robust RNAi response normally prevented
widespread infection by ONNV in An. gambiae. Injection of
dsRNAs targeting Aa-dcr2 and Aa-ago2 mRNAs reversed RNAi-
based DENV2 resistance in the Carb77 transgenic line [23] (Franz
and Olson, unpublished data). In the current study, we
intrathoracically injected HWE mosquitoes with dsRNA.dcr2,
dsRNA.ago2 or dsRNA.r2d2 prior to DENV2 infection and
showed reduced corresponding mRNA 2 days later, at the time of
infection. We observed that reduced expression of key RNAi genes
resulted in increased mean virus titers in mosquitoes at 7 dpi.
Injection of dsRNA.dcr2 was most effective for mRNA knock-
down, and targeting Aa-dcr2 by dsRNA.dcr2 injection caused the
largest increase in infection rate and virus titers. The average titer
for mosquitoes injected with dsRNA.dcr2 was .10-fold higher
than the average titer of control dsRNA-treated mosquitoes and a
small but significant number of dsRNA.dcr2- and dsRNA.ago2-
injected mosquitoes had virus titers 100-fold higher than in control
infections. If expression of RNAi component genes and activity of
the RNAi pathway is variable among vector populations this may
explain in part observed differences in vector competence [38].
We are currently determining whether there are genetic
associations between RNAi genes such as Aa-dcr2 and vector
competence [39].
Finally, given the increase in DENV2 titers in dsRNA.dcr2-,
dsRNA.r2d2- and dsRNA.ago2-treated mosquitoes, we asked
whether the EIP is affected in mosquitoes with an impaired
RNAi pathway. In mosquitoes pre-treated with dsRNA.dcr2,
DENV2 transmission was detected as early as 7 dpi, indicating a
shorter EIP when this defense mechanism was diminished. This
could have significant epidemiological implications for DENV2
transmission, affecting vectorial capacity, which includes vector
competence, but also incorporates all the other biological,
behavioral, and ecological attributes of the vector that function
in virus transmission. If the adult female mosquito has a shorter
EIP and transmits virus more quickly after infection, the
mosquito will have more opportunities to transmit virus during
its lifetime.
Figure 5. Transmission of DENV2 by Ae. aegypti at 7, 10, and 12 days post infection. Groups of 200 mosquitoes were non-injected or
injected with PBS or 500 ng dsRNA.bGAL, dsRNA.ago2, dsRNA.r2d2, or dsRNA.dcr2. Two days later all mosquito groups were orally infected with
DENV2. At 7 (A), 10 (B) and 12 (C) dpi multiple batches of 10 mosquitoes were allowed to probe artificial feeding solutions. The feeding solutions were
assayed for virus titer (* indicate P,0.05).
doi:10.1371/journal.ppat.1000299.g005
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limits on RNA virus replication and in the absence of RNAi,
DENV2 and other arboviruses may increase their amplification to
levels that begin to compromise vector fitness. This situation has
been observed in Drosophila with dcr2 or ago2 loss-of-function
mutations that are highly vulnerable to RNA virus infections due
to disabled RNAi responses [10]. Although we believe that the
early innate immune response is important in limiting virus
replication in mosquitoes, injection of dsRNA results in a transient
impairment of the RNAi defense system and longer-term
suppression induced by a genomic mutation might cause a more
pronounced and effective response. Future work should lead
toward understanding natural variations in expression of RNAi
pathway genes in vector populations and resulting effects on
DENV infection and transmission. We are currently developing
null-mutants for dcr2 in Ae. aegypti to more fully understand the role
of this RNAi pathway gene in vector competence and vectorial
capacity, and determine the possible effect of RNAi on infection of
the vector by various DENV2 genotypes.
Variations in interaction of DENVs with the RNAi pathway
could also have implications for determining why certain
genotypes of DENVs are more efficiently transmitted than other
genotypes and help explain the rapid spread of potentially virulent
genotypes in the Americas [40,41]. We hypothesize that DENV2
genotypes that most effectively circumvent RNAi would more
efficiently replicate and be transmitted. An important question is
how do arboviruses like DENV2 evade RNAi? Pathogenic RNA
viruses of insects such as drosophila C virus express RNAi
suppressors that increase viral pathogenicity, thus facilitating virus
transmission to other insects [10,42]. However, for efficient
transmission of arboviruses to vertebrate hosts during acquisition
of blood meals by the mosquito, it may be advantageous for the
virus not to harm the vector. Indeed, the balance between RNAi
activity in the vector and viral circumvention mechanisms might
be a determinant in maintenance of the persistent virus infection.
The La Crosse virus (LACV; Bunyaviridae) nonstructural protein
NSs was reported to suppress RNAi in mammalian cells [43], but
other studies have demonstrated that in mosquito cells persistently
infected with recombinant LACV, expression of functional NSs
protein has no effect on specific RNAi responses [44]. Another
mechanism arboviruses may use to evade RNAi is minimizing
early detection of the dsRNA trigger by the RNAi machinery.
Geiss et al. [31] showed a significant reduction in WNV RNA in
mammalian cells that were pre-treated with virus-specific siRNAs;
however, cells that were treated subsequent to the establishment of
viral replication did not have the same reduction in viral mRNA,
suggesting that replicating viral RNA may be sequestered from the
RNAi machinery in the cell. Identifying possible mechanisms of
RNAi suppression or evasion associated with DENV2 infections is
now being pursued.
Others have recently suggested that West Nile virus (WNV;
Flaviviridae) fails to trigger RNAi in cultured C6/36 (Ae. albopictus)
mosquito cells; however, the RNAi response in Drosophila appears
to be protective against WNV infection [45]. We show here that
the RNAi pathway in Ae. aegypti is not completely protective
against DENV2 infection but modulates replication, suggesting
that DENV2 has co-adapted to the major vector’s RNAi response
in ways as yet undefined. We hypothesize that RNAi is critical to
maintaining a persistent virus infection in the vector, leading to
long-term survival of the infected mosquito and efficient
transmission of the virus with each successive blood meal.
Important goals of future studies will be to determine how the
virus mitigates the effects of RNAi in the vector, whether RNAi
interacts with other innate defenses such as Toll pathway
responses, and the consequences of impaired RNAi on vector
fitness following infection with arboviruses.
Materials and Methods
Virus and cell culture
LLC-MK2 monkey kidney cells and C6/36 (Ae. albopictus) cells
were cultured in modified Eagle’s medium (MEM) supplemented
with 8% fetal bovine serum, L-glutamine, non-essential amino
acids and penicillin/streptomycin and maintained at 37uC and
28uC, respectively. Aag2 (Ae. aegypti) cells were cultured in
Schneider’s Drosophila medium with 10% fetal bovine serum,
L-glutamine, non-essential amino acids and penicillin/streptomy-
cin and maintained at 28uC. High passage DENV2 (Jamaica 1409)
was used to infect fresh cultures of C6/36 cells to prepare
infectious blood meals. Briefly, monolayers of C6/36 cells were
inoculated with DENV2 at a MOI of 0.01 and held at 28uC;
6 days later medium was replaced and infected cells and medium
were harvested at 12–14 days.
Infectious virus titration by plaque assay
LLC-MK2 cells were grown to confluent monolayers in 24-well
plates, infected with 10-fold serial dilutions of virus for 1 hour,
then overlaid with an agarose-nutrient mixture. After 7 days
incubation at 37uC cells were stained with 5 mg/ml MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) solution
and incubated for 4 hours [46,47]. Viral titers were determined
by counting plaques. Individual mosquitoes were triturated in
1.0 ml of L15 medium to release infectious virus as previously
described [23]. Individual mosquito titers are reported as plaque
forming units (pfu) per ml (values are expressed as the means
6SEM).
Mosquito rearing and infection with arboviruses
Ae. aegypti HWE mosquito eggs were hatched from an egg liner
(containing 10,000–100,000 eggs) in 150 ml of deionized,
autoclaved water. Larvae were transferred to a large rearing
pan, collected as pupae 7–9 days later, transferred to an
emergence container within a cage and maintained in the
insectary at 28uC, 82% relative humidity until adult mosquitoes
were harvested. Groups of 200 one-week-old adult females were
placed in 2.5 liter cartons, deprived of sugar source overnight and
allowed to feed on artificial blood meals consisting of virus-infected
C6/36 cell suspension (60% vol/vol), 40% (vol/vol) defibrinated
sheep blood (Colorado Serum Co., Boulder, CO) and 1 mM ATP.
Virus titers were usually 10
6–10
7 pfu/ml for DENV2 [48]. The
artificial blood meal was prewarmed to 37uC and then pipetted
into water-jacketed glass feeders covered with a hog gut
membrane and maintained at a constant temperature of 37uC.
Feeders were placed onto the net covering the cartons to allow
females to feed through the hog gut membrane for 1 h. Fed
females were selected, put into new cartons, provided with water
and sugar and maintained in the insectary for analysis.
Northern blot analysis of mRNA
Viral RNA and mRNA originating from endogenous mosquito
genes were analyzed by northern blot hybridization performed as
described [49]. Briefly, total RNA was extracted from mock or
DENV2 infected Aag2 cells (MOI=0.05) or whole mosquitoes
using Trizol reagent (Invitrogen) following the manufacturer’s
instructions; 3–5 mg of total RNA were electrophoresed in a 1.2%
agarose gel and blotted onto a positively charged nylon membrane
(Ambion). Blots were hybridized with antisense
32P-UTP-labeled
RNA probes that were transcribed in vitro from linearized
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from the specific sequence of DENV-2 (prM), Aa-dcr2, Aa-r2d2 or
Aa-ago2 RNA., and hybridization was visualized using a phos-
phorimager. Alternatively, random-primed
32P-dCTP-labeled
DNA probes were generated from the same template by using
the Megaprime DNA Labeling Kit (Amersham Pharmacia
Biosciences).
Northern blot analysis of siRNA
Approximately 50 mg of total RNA obtained from mock or
DENV2 infected Aag2 cells (Fig 1D) or 50 mg of total RNA from
60 mosquitoes (Fig 3C) were loaded per lane onto a 15%
polyacrylamide-TBE-urea denaturing gel and separated by
electrophoresis. RNA was electrophoretically transferred to a
non-charged nylon membrane and chemically cross-linked to the
membrane using carbodiimide [50]. The membrane was incubat-
ed in UltraHyb (Ambion) hybridization buffer at 42uC for
30 minutes. For detecting siRNAs from infected Aag2 cells or
mosquitoes, single-stranded RNA probes were transcribed in sense
or antisense orientation from the 498 bp cDNA encoding the
DENV2 prM gene using the MEGAscript kit (Ambion), with
approximately 9% of the UTP in the transcription reaction
conjugated to biotin for detecting siRNA from Aag2 or with
32P-
UTP for detecting siRNA from mosquitoes. Five micrograms of
labeled sense or antisense RNA were hydrolyzed to 50–100 nt
fragments in 200 mM carbonate buffer at 60uC for approximately
2.5 hours. Probe was added to the UltraHyb buffer after the pre-
hybridization and incubated for 16 hr at 42uC. The membrane
was washed twice with 26 SSC-0.1% SDS for 5 minutes each,
followed by two washes in 0.16 SSC-0.1% SDS for 15 minutes
each. Biotin-labeled probes were detected with the BrightStar
BioDetect Kit (Ambion) and membranes were exposed to X-ray
film for 18 hours (Fig. 1D), and
32P-labeled probes were detected
using a phosphorimager (Fig. 3C).
Detection of siRNAs derived from DENV2 RNA in
mosquito midguts
siRNAs were enriched from 200 mg total midgut RNA
extracted from female mosquitoes 1–14 days post bloodmeal
according to a previously described protocol [23]. High molecular-
weight RNA was precipitated by addition of 5% (wt/vol)
polyethylene glycol (Mr 8,000) and 0.5 M NaCl. Supernatants
containing siRNAs were analyzed in a ribonuclease protection
assay by using the mirVana miRNA Detection Kit (Ambion). For
nuclease protection, siRNAs were hybridized with an antisense
RNA probe 30 nt in length containing 22 nt of sequence
complementary to a portion of the prM-encoding region of
DENV2 RNA (Integrated DNA Technologies, Colorado State
University). RNA probes were end-labeled with [c-
32P] ATP.
Hybridizations were performed at 42uC. After RNase digestion,
hybridized RNA samples were electrophoretically separated on a
16% polyacrylamide gel containing 7 M urea.
Detection of dsRNA in Aag2 cells and midguts using J2
antibody
Aag2 cells were infected with DENV2 at a MOI of 0.1 and Ae.
aegypti mosquitoes were given a non-infectious or infectious blood
meal containing ,10
6 pfu/ml of virus. Both cells and midguts
were fixed in 4% paraformaldehyde in PBS at 4–5 dpi and 7 dpi,
respectively. dsRNA was detected using J2 antibody (Scicons,
Hungary) as previously described with minor modifications [33].
All images were taken with a Leica DM 4500B microscope.
Generation of dsRNA and delivery to mosquitoes
Oligonucleotide primers incorporating T7 RNA polymerase
promoter sequences at the 59 ends were designed to amplify ,500-
bp regions of RNAi pathway genes (Table 1) to serve as
transcription templates for dsRNAs for Aa-dcr2, Aa-r2d2 and Aa-
ago2 according to the method previously described [25]. One week
old adult female mosquitoes were intrathoracically injected with
500 ng of each dsRNA prior to infection.
Analysis of virus transmission potential
Groups of 200 Ae. aegypti HWE mosquitoes were intrathorac-
ically injected with dsRNA.r2d2, dsRNA.ago2, dsRNA.dcr2,
dsRNA.bGAL (500 ng dsRNA/mosquito), or PBS. A separate
group of mosquitoes was not injected. Two days later all mosquito
groups were challenged with an infectious blood meal containing
6.6610
6 pfu/ml of DENV2. At pre-determined times, groups of
10 mosquitoes were allowed to probe and feed on 350 mlo fa
feeding solution (50% FBS/164 mM NaCl/100 mM NaHCO3/
0.2 mM ATP/,50 mg sucrose/phenol red, pH 7) that was placed
between two parafilm membranes stretched over a glass feeder.
After probing, mosquitoes and feeding solutions were collected
and prepared for plaque assays [23].
Statistical analysis
To determine if impairment of the RNAi pathway in
mosquitoes has an effect on virus replication and EIP, data were
subjected to analysis of variance (ANOVA) using the general linear
model of SAS (SAS User’s Guide, Cary, NC: Statistical Analysis
System Institute, Inc., 1987). Sources of variation for virus titer in
mosquitoes were treatment (non-injected, dsRNA.bGAL-,
dsRNA.Aa.ago2-, dsRNA.Aa.r2d2-, and dsRNA.Aa.dcr2-injected)
and replicate (4); and for feeding solution titer were treatment
(non-injected, PBS-, dsRNA.bGAL-, dsRNA.Aa.ago2-,
dsRNA.Aa.r2d2-, and dsRNA.Aa.dcr2-injected), replicate (2),
days post-infection (7, 10, and 12), and the effect of treatment
by day post infection. Since variation between replicates was not
significant, it was removed from the model. If variances were not
homogeneous, data were subjected to log 10 transformations.
When differences among treatment means were detected, they
were separated using least significant difference (LSD) procedure.
The effect of treatments on the number of mosquitoes infected and
on the number of feeding solutions infected was analyzed by chi-
square test (SAS). For the number of mosquitoes infected each
experimental group was compared to the non-injected group; for
the number of feeding solutions infected each experimental group
was compared to the average of the three control groups.
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